A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS.

The public will have their say at a May hearing into Ali Williams and Anna Mowbray’s plans for a helicopter pad at their $24 ...